Examiner: HECK, BRYAN WILLIAM

Tech Center 1600 • Art Units: 1643

This examiner grants 46% of resolved cases

Performance Statistics

45.7%

Allow Rate

-14.3% vs TC avg

Total Applications

+69.4%

Interview Lift

1307

Avg Prosecution Days

Based on 46 resolved cases, 2023–2026

6.1%

§101 Eligibility

18.2%

§102 Novelty

23.5%

§103 Obviousness

35.6%

§112 Clarity

App #	Title	Status	Assignee
18349012	METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R ANTAGONIST	Non-Final OA	REGENERON PHARMACEUTICALS, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.